| Literature DB >> 33175882 |
Benjamin W Nelson1,2,3, Adam Pettitt1, Jessica E Flannery1,2,3, Nicholas B Allen1.
Abstract
COVID-19 emerged in November 2019 leading to a global pandemic that has not only resulted in widespread medical complications and loss of life, but has also impacted global economies and transformed daily life. The current rapid response study in a convenience online sample quickly recruited 2,065 participants across the United States, Canada, and Europe in late March and early April 2020. Cross-sectional findings indicated elevated anxiety and depressive symptoms compared to historical norms, which were positively associated with COVID-19 concern more strongly than epidemiological data signifying risk (e.g., world and country confirmed cases). Employment loss was positively associated with greater depressive symptoms and COVID-19 concern, and depressive symptoms and COVID-19 concern were significantly associated with more stringent self-quarantine behavior. The rapid collection of data during the early phase of this pandemic is limited by under-representation of non-White and middle age and older adults. Nevertheless, these findings have implications for interventions to slow the spread of COVID-19 infection.Entities:
Mesh:
Year: 2020 PMID: 33175882 PMCID: PMC7657530 DOI: 10.1371/journal.pone.0241990
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Participant location.
A. United States, Canada, and Europe, B. Zoomed Image of United States and Canada, C. Zoomed Image of Europe.
Fig 2Description of participant demographics.
Fig 3Description of COVID-19 health variables.
Fig 4Behavioral changes due to COVID-19.
Fig 5Financial strain.
Fig 6Mean a) GAD-2 and b) PHQ-2 Total Scores and Clinical Diagnostic Cutoff Compared to Historical General Population Mean Total Scores. Note: Solid Black Line = GAD-2 and PHQ-2 Historical General Population Mean Total Scores; Dotted Red Line = Threshold for Clinical Diagnosis; Grey Dashed Line error bars = Standard Error; GAD-2 = Generalized Anxiety Disorder-2; PHQ-2 = Patient Health Questionnaire-2; *** = p < .001.
Fig 7A. GAD-2 and B. PHQ-2 diagnostic threshold by level of COVID-19 concern.